169 Yb-based high dose rate intensity modulated brachytherapy for focal treatment of prostate cancer.

Maude RobitailleCynthia MénardGabriel FamulariDominic Béliveau-NadeauShirin A Enger

Published in: Brachytherapy (2024)

Yb-based HDR IMBT for focal treatment of prostate cancer has the potential to successfully deliver clinically acceptable, less invasive treatment with reduced dose to organs at risk.

Keyphrases

prostate cancer
high dose
radical prostatectomy
low dose
squamous cell carcinoma
stem cell transplantation
climate change
replacement therapy
rectal cancer